TM6SF2 and metabolic dysfunction-associated steatotic liver disease: Recent studies, including a pilot study by our group, have shown that the TM6SF2 E167K [6–8] and PNPLA3 I148M [9–11] polymorphisms are both associated with the development of NAFLD.